MeSH term
Frequency | Condition_Probility | Female | 47 | 0.0 |
Humans | 147 | 0.0 |
Animals | 53 | 0.0 |
Carrier Proteins/genetics/*metabolism | 6 | 1.0 |
Cholesterol/blood | 8 | 0.0 |
Immunoglobulin M/blood | 2 | 1.0 |
Kinetics | 15 | 0.0 |
Lipoproteins/*blood | 6 | 1.0 |
Mice | 27 | 0.0 |
Mice, Knockout | 7 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
*Phospholipid Transfer Proteins | 122 | 76.0 |
Phospholipids/blood | 13 | 9.0 |
Research Support, Non-U.S. Gov't | 97 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 39 | 0.0 |
Triglycerides/blood | 14 | 1.0 |
Vitamin E/*blood | 2 | 9.0 |
Lipoproteins/*metabolism | 6 | 3.0 |
Phospholipids/*metabolism | 16 | 13.0 |
Lipoproteins, HDL/metabolism | 14 | 13.0 |
Liver/metabolism | 4 | 0.0 |
Male | 65 | 0.0 |
Membrane Proteins/blood | 8 | 20.0 |
Middle Aged | 51 | 0.0 |
Apolipoproteins B/*blood | 3 | 1.0 |
Body Mass Index | 5 | 0.0 |
Carrier Proteins/*blood | 35 | 14.0 |
Comparative Study | 16 | 0.0 |
Diabetes Mellitus, Type 2/*blood | 5 | 4.0 |
Lipoproteins/blood | 8 | 2.0 |
Lipoproteins, HDL/blood | 6 | 2.0 |
Membrane Proteins/*blood | 27 | 49.0 |
Reference Values | 10 | 0.0 |
Adipose Tissue/*metabolism | 2 | 1.0 |
Adult | 46 | 0.0 |
Aged | 17 | 0.0 |
Apolipoproteins B/blood | 4 | 1.0 |
Carrier Proteins/blood/*metabolism | 5 | 23.0 |
Diet | 2 | 0.0 |
Insulin Resistance | 4 | 2.0 |
Lipoproteins, LDL/*blood | 2 | 1.0 |
Lipoproteins, LDL Cholesterol/blood | 4 | 0.0 |
Membrane Proteins/blood/*metabolism | 4 | 66.0 |
Sex Factors | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Biological Transport | 15 | 1.0 |
Carrier Proteins/*genetics/metabolism | 5 | 2.0 |
Cloning, Molecular | 6 | 0.0 |
DNA, Complementary | 2 | 0.0 |
*Glycoproteins | 52 | 6.0 |
Membrane Proteins/*genetics/metabolism | 5 | 3.0 |
Molecular Sequence Data | 13 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Rabbits | 7 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Lipids/*blood | 6 | 1.0 |
Lipoprotein Lipase/*blood | 4 | 3.0 |
Lipoproteins, LDL Cholesterol/*blood | 3 | 3.0 |
Multivariate Analysis | 3 | 0.0 |
Particle Size | 15 | 5.0 |
Carrier Proteins/*physiology | 3 | 1.0 |
Cholesterol/metabolism | 11 | 3.0 |
Lipoproteins, VLDL/metabolism | 4 | 3.0 |
Membrane Proteins/*physiology | 3 | 2.0 |
Mice, Inbred C57BL | 11 | 0.0 |
Immunoblotting | 3 | 0.0 |
Lipoproteins, HDL Cholesterol/*metabolism | 2 | 5.0 |
Lipoproteins, HDL Cholesterol/*blood | 7 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Chromatography, Affinity | 3 | 0.0 |
Chromatography, Gel | 5 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Lipids/blood | 13 | 2.0 |
Phospholipids/metabolism | 6 | 3.0 |
Blotting, Northern | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 5 | 0.0 |
Insulin/*pharmacology | 3 | 1.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Lipase/blood | 3 | 4.0 |
Liver/enzymology | 4 | 0.0 |
Mice, Transgenic | 10 | 0.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/blood | 6 | 8.0 |
Time Factors | 6 | 0.0 |
Base Sequence | 9 | 0.0 |
Carrier Proteins/*genetics | 4 | 0.0 |
Cell Line | 6 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Membrane Proteins/*genetics | 4 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Membrane Proteins/*blood/chemistry | 3 | 75.0 |
Ultracentrifugation | 2 | 1.0 |
Antilipemic Agents/administration & dosage/*therapeutic use | 2 | 50.0 |
Apolipoprotein A-I/blood | 4 | 3.0 |
Apolipoprotein A-II/blood | 2 | 10.0 |
Lipoproteins, HDL/*blood | 11 | 5.0 |
Apolipoprotein A-I/genetics | 2 | 10.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
Lipoproteins, HDL/*metabolism | 17 | 14.0 |
Liver Neoplasms | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 2 | 1.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Lipoproteins/metabolism | 5 | 4.0 |
Biological Transport/drug effects | 3 | 1.0 |
Cells, Cultured | 9 | 0.0 |
Cholesterol/*metabolism | 6 | 2.0 |
Infusions, Intravenous | 3 | 0.0 |
Antilipemic Agents/*pharmacology | 2 | 5.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
Procetofen/*pharmacology | 2 | 28.0 |
Carrier Proteins/*metabolism | 12 | 1.0 |
Membrane Proteins/*metabolism | 12 | 2.0 |
Protein Binding | 3 | 0.0 |
Protein Denaturation | 3 | 1.0 |
Triglycerides/metabolism | 2 | 1.0 |
Membrane Proteins/genetics/*metabolism | 4 | 1.0 |
Sequence Alignment | 5 | 0.0 |
Multigene Family | 2 | 0.0 |
Blood Glucose/analysis | 3 | 0.0 |
Cholesterol/*blood | 5 | 2.0 |
Fasting | 3 | 0.0 |
Insulin/blood | 4 | 0.0 |
*Insulin Resistance | 3 | 1.0 |
Lipoproteins, HDL Cholesterol/blood | 10 | 1.0 |
Lipoproteins, HDL/blood/drug effects | 2 | 100.0 |
Membrane Proteins/chemistry/*physiology | 2 | 10.0 |
Models, Molecular | 2 | 0.0 |
Obesity/metabolism | 2 | 4.0 |
Cholesterol Esters/*metabolism | 2 | 2.0 |
Cross-Sectional Studies | 2 | 0.0 |
Sex Characteristics | 3 | 0.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/metabolism | 3 | 5.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/*blood | 7 | 6.0 |
Binding, Competitive | 2 | 0.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Thimerosal/pharmacology | 2 | 50.0 |
*Acute-Phase Proteins | 5 | 2.0 |
Binding Sites | 3 | 0.0 |
Carrier Proteins/*blood/genetics | 2 | 10.0 |
Electrostatics | 2 | 1.0 |
*Membrane Glycoproteins | 5 | 0.0 |
Mutation | 3 | 0.0 |
Recombinant Proteins/metabolism | 6 | 0.0 |
Antibodies, Monoclonal | 3 | 0.0 |
CHO Cells | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay/methods | 2 | 0.0 |
Hamsters | 7 | 0.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
Lipoproteins, HDL/*chemistry | 2 | 11.0 |
Temperature | 2 | 0.0 |
Carrier Proteins/blood | 4 | 3.0 |
Carrier Proteins/*blood/chemistry | 2 | 40.0 |
Molecular Weight | 5 | 0.0 |
Osmolar Concentration | 2 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Cholesterol Esters/*blood | 6 | 7.0 |
Carrier Proteins/metabolism | 4 | 0.0 |
Lipase/metabolism | 3 | 5.0 |
Blotting, Western | 7 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Rats | 5 | 0.0 |
Antigens, CD14/metabolism | 2 | 1.0 |
Apolipoprotein A-I/analysis | 2 | 10.0 |
Carrier Proteins/*blood/*genetics | 3 | 30.0 |
*Gene Expression | 3 | 0.0 |
Macrophages, Peritoneal/metabolism | 2 | 8.0 |
Membrane Proteins/*blood/*genetics | 2 | 100.0 |
Lipoproteins, HDL Cholesterol/blood/*metabolism | 2 | 25.0 |
Liver/*metabolism | 3 | 0.0 |
Cohort Studies | 3 | 0.0 |
Lipoproteins, LDL/blood | 2 | 0.0 |
Lipolysis | 2 | 2.0 |
Analysis of Variance | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Phosphatidylcholines/metabolism | 3 | 3.0 |
Electrophoresis, Gel, Two-Dimensional/methods | 2 | 9.0 |
Lipoproteins, VLDL/blood | 4 | 1.0 |
Lipoproteins, LDL/metabolism | 5 | 2.0 |
Hela Cells | 3 | 0.0 |
*Mutagenesis, Site-Directed | 2 | 2.0 |
Structure-Activity Relationship | 5 | 0.0 |
Gene Expression | 4 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
COS Cells | 3 | 0.0 |
Carrier Proteins/blood/genetics/*metabolism | 2 | 28.0 |
Membrane Proteins/blood/genetics/*metabolism | 2 | 66.0 |
Biological Transport, Active/drug effects | 2 | 3.0 |
In Vitro | 3 | 0.0 |
Phospholipids/*blood | 5 | 15.0 |
Double-Blind Method | 4 | 0.0 |
Peptide Fragments/chemistry/metabolism | 3 | 2.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Cholesterol Esters/blood | 8 | 6.0 |
Enzyme-Linked Immunosorbent Assay/*methods | 2 | 1.0 |
Risk Factors | 5 | 0.0 |
Transfection | 6 | 0.0 |
Species Specificity | 3 | 0.0 |
Fatty Acids, Nonesterified/blood | 3 | 1.0 |
Lipase/*metabolism | 4 | 7.0 |
Liver/*enzymology | 3 | 0.0 |
Apolipoprotein A-I/*blood | 2 | 6.0 |
Adenoviridae | 2 | 2.0 |
Genetic Vectors | 2 | 0.0 |
Apolipoprotein A-I/metabolism | 2 | 2.0 |
Swine | 5 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Alcoholism/*blood | 2 | 12.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
*Phospholipids | 2 | 40.0 |
Cholesterol Esters/metabolism | 5 | 4.0 |
RNA, Messenger/analysis/metabolism | 2 | 1.0 |
Liposomes/metabolism | 2 | 3.0 |
Pyrenes/metabolism | 2 | 20.0 |
Lipoproteins, HDL/*blood/chemistry | 2 | 18.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Chromatography, Liquid | 2 | 1.0 |
Apolipoprotein A-I/chemistry/metabolism | 2 | 50.0 |
Microscopy, Electron | 2 | 0.0 |
Apolipoproteins/blood | 3 | 1.0 |
Blood Proteins/*metabolism | 2 | 1.0 |
Biological Markers | 2 | 0.0 |
Molecular Conformation | 2 | 0.0 |
Lipids/metabolism | 2 | 0.0 |
Macrophages/metabolism | 2 | 0.0 |
Membrane Proteins/blood/metabolism | 3 | 75.0 |
Carrier Proteins/blood/metabolism | 2 | 33.0 |
Linear Models | 2 | 0.0 |
Insulin Resistance/*physiology | 2 | 2.0 |
Carrier Proteins/analysis/genetics/*metabolism | 2 | 33.0 |
Cholesterol/pharmacology | 2 | 13.0 |
Immunohistochemistry | 3 | 0.0 |
Membrane Proteins/analysis/genetics/*metabolism | 2 | 25.0 |
Foam Cells/*metabolism | 2 | 14.0 |
Macrophages/*metabolism | 2 | 0.0 |
